Holen Sie sich die Stockscreener-App
0.16
54.29%
-0.19
Molecular Templates Inc Aktie (MTEM) Neueste Nachrichten
MTEM stock touches 52-week low at $0.15 amid sharp annual decline - Investing.com
Molecular Templates faces Nasdaq delisting By Investing.com - Investing.com Canada
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.18% - Investing.com
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Why Molecular Templates (MTEM) Stock Is Down 60% - Benzinga
MTEM stock touches 52-week low at $0.15 amid sharp annual decline By Investing.com - Investing.com South Africa
Molecular Templates faces Nasdaq delisting - Investing.com
Molecular Templates Announces Notice of Delisting and Failure to Satisfy Continued Listing Rules - The Manila Times
Molecular Templates Faces Nasdaq Delisting After Multiple Compliance Failures - StockTitan
Best Biotech Penny Stocks Right Now • Updated Daily - Benzinga
Why DocuSign Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Inkl
Dyne Therapeutics (DYN) Stock Drops Amidst Biotech Sector Moveme - GuruFocus.com
Artelo Biosciences (ARTL) Stock Surges 5% Amid Strong Buy Ratings - GuruFocus.com
Stock market news: Molecular Templates increased by 60.83% while Algorhythm Holdings dipped by 47.40% during mid day trading - Business Upturn
Molecular Templates Announces Key Leadership Transition - TipRanks
Molecular Templates, Inc. Announces Executive Changes - Marketscreener.com
Molecular Templates Announces Receipt of Expected Notification of Deficiency from Nasdaq Related to Delayed filing of Quarterly Report on Form 10-Q and Failure to Meet Bid Price Requirements - Marketscreener.com
Molecular Templates Faces Dual Nasdaq Compliance Warnings Over Filing, Stock Price - StockTitan
Stock Region Signal Report - substack.com
Molecular Templates faces delisting, seeks stockholder approval for dissolution - Investing.com India
Molecular Templates faces delisting, seeks stockholder approval for dissolution By Investing.com - Investing.com Australia
Compugen (CGEN) Stock Dips Amidst Biotech Sector Movements - GuruFocus.com
Capricor Therapeutics (CAPR) Stock Surges Amid Positive Analyst Ratings - GuruFocus.com
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.47% - MSN
United States shares lower at close of trade; Dow Jones Industrial Average down 0.47% - MSN
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.47% - MSN
BB Biotech AG's Strategic Acquisition in Molecular Templates Inc - GuruFocus.com
Alphabet Cl A (GOOGL-Q) QuotePress Release - The Globe and Mail
Bb Biotech sells $845,833 in Molecular Templates shares - Investing.com India
Bb Biotech sells $845,833 in Molecular Templates shares By Investing.com - Investing.com UK
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT)’s Stock Reduces -12.58%, Making It A Good Investment - Stocks Register
Analysts Predict Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) To Loss -577.97% From Current Levels. - Stocks Register
Molecular Templates Inc (NASDAQ: MTEM) Drops -23.41 Percent In Recent Session, Why Are You Interested? - Stocks Register
Layoff Tracker: Adaptimmune Downsizes by 33% in Strategic Realignment - BioSpace
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
HALO Stock Dips 5.77% Amid Biotech Sector Changes - GuruFocus.com
Agenus (AGEN) Stock Dips Amid Financial Performance and Industry Trends - GuruFocus.com
U.S. STOCKS Talen Energy, Biogen, Ovintiv - XM
U.S. Stock market: Molecular Templates surges by 155.81% while Sow Good declines by 53.39% during mid day trading - Business Upturn
Austin InnoProper Good heads to the big box | Austin startups on the Deloitte Fast 500 - The Business Journals
Clairity Appoints Jeffrey R. Luber CEO as Firm Prepares for Global Expansion - cnhinews.com
Clairity Appoints Jeffrey R. Luber as CEO - citybiz
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):